Ligand Pharmaceuticals 10K 2022 Annual report | LGND Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: AAA, abbreviated, abroad, adrenoleukodystrophy, adrenomyeloneuropathy, adversarial, aldehyde, AMD, amenable, AMN, Anderson, Andrew, APAC, arm, ATM, attack, attorney, authorizationb, Avista, basal, Beijing, berdazimer, Berkman, binary, block, Boulevard, breadth, bronchodilator, build, cap, CCPA, CEO, charitable, Cochran, Coinciding, Colorado, commonplace, compound, confirmatory, Connecticut, construction, constructive, contended, contra, conveyance, counsel, COVID, CPRA, CRDC, creditor, Defense, degeneration, degradation, denial, deployed, deployment, DGCL, disadvantage, dissuade, dry, effectuated, Espinoza, exacerbate, fashion, fifteen, FILSPARI, focal, Foehr, freedom, FY, Fycompa, gap, Gorlin, GS, hacking, headcount, HHS, Hispanic, holding, illegally, IM, immunoglobulin, immunomodulatory, indemnify, injunctive, inside, instability, intrusion, inventor, inventorship, ipilimumab, IRA, IRS, isatuximab, Jennifer, KCRC, largest, literature, LM, lump, lymphatic, LYTENAVA, macular, maker, mandated, media, Median, microcystic, mid, military, misuse, MLM, Mustard, Nitrogen, nivolumab, numerically, OABI, Octavio, ocular, OminAb, ophthalmic, opposed, organizational, Orwell, OTORIN, outlook, outpace, outreach, Park, Patel, penalize, permission, phishing, phosphodiesterase, physical, polymerase, Portability, premise, prevail, prohibited, prohibition, proportionately, prosecute, prosecuted, prosecution, proteasome, RASP, rata, ratio, RCC, RdRp, reactive, reallocate, Reardon, reassigned, refund, regaining, regime, relief, reorganization, reorganized, repay, reproxalap, resigned, resurgence, RNA, route, Russia, saleable, Secretary, software, solar, solvent, Southeast, steady, stem, Stifel, strength, substantive, Sunil, theft, therewith, threatened, transplantation, treble, trend, Tribunal, Ukraine, unamortized, unclear, underpaid, unlawful, unpaid, unreasonably, unwilling, USPTO, Utah, viable, Virginia, voiding, voluntarily, water, wet, wider, willfully

Removed: Abvivo, accreditation, adenosine, affiliate, Alembic, AlivaMab, angiography, animal, answer, antigen, Aptevo, ASCO, assay, atezolizumab, bear, Beecham, Bexson, bioequivalence, BioMed, Biomedical, bispecific, blockade, CanGaroo, castration, cellular, channel, chronically, classical, collateral, comparison, complaint, contrast, conveyed, coronary, counterclaimed, CStone, cystic, debilitating, declaratory, Derecognition, diagnostic, direction, discovering, double, ECM, Emeryville, enable, enhanced, Envelope, equipped, esaxerenone, estate, exhibit, expanded, explore, fact, failed, fatty, Francisco, fungal, Genagon, Genitourinary, genmab, GigaGen, glomerular, Gloria, GPCR, HanAll, Harbour, HBeAg, heading, heart, Hodgkin, holdback, host, humane, hypertension, IgA, imaging, iMetabolic, immune, immunotherapy, Immunovant, implantable, indemnification, interested, intervention, intravascular, iodinated, Iohexol, ion, irrevocable, Janssen, KGaA, killer, Korea, Kymouse, larger, Latin, letter, lifelong, light, load, local, lt, Lupin, malignant, mediated, mentioned, Mexico, mg, mice, Millennium, mineralocorticoid, monogenic, mouse, muscle, myasthenia, naturally, nephroprotective, Nonfinancial, nonprofit, OmniChicken, OmniClic, OmniFlic, OmniMouse, omnipaque, OmniRat, optimized, partnership, pathogenic, payoff, pericardial, pevonedistat, pharmacokinetic, Pharmacopeia, planned, prejudice, premium, produce, progression, Promacta, prostate, proteinuria, PTX, pursued, reclassified, recurrent, referenced, regrowth, repair, Republic, resistant, RPI, SA, safer, secure, securing, seizure, setting, Shanghai, showing, side, skeletal, SmithKline, South, spectrum, successor, superfamily, Suzhou, Switzerland, Symphogen, Symposium, synergistic, targeted, TDF, thereto, tolerability, tolerable, tolerate, tomography, toxicity, tumor, typical, undisclosed, Valanbio, VelocImmune, VentiRx, Viviant, wasting, WuXi


Name						Jurisdiction of Incorporation
Allergan Ligand Retinoid Therapeutics, Inc.						Delaware
Aramed Inc.						Delaware
Cita NeuroPharmaceuticals Inc.						Canada
CyDex Pharmaceuticals, Inc.						Delaware
Glycomed Incorporated						California
Ligand Biopharmaceuticals Incorporated						Delaware
Ligand Holdings UK Limited						England and Wales
Ligand JVR, Inc.						Delaware
Ligand Pharmaceuticals (Canada) Incorporated						Canada
Ligand Pharmaceuticals International, Inc.						Delaware
Ligand Pharmaceuticals UK Limited						United Kingdom
Ligand UK Development Limited						England and Wales
Ligand UK Group Limited						England and Wales
Ligand UK Limited						England and Wales
Ligand UK Research Limited						England and Wales
Metabasis Therapeutics, Inc.						Delaware
Neurogen Corporation						Delaware
Pfenex Inc.						Delaware
Pharmacopeia, LLC						Delaware
Seragen Incorporated						Delaware
Seragen Technology, Inc.						Delaware
Vernalis Therapeutics Inc.						Delaware
Verrow Pharmaceuticals						Kansas

Ligand Pharmaceuticals (LGND) 10-K2022 FY Annual report

Content analysis